Non-dipping heart rate and microalbuminuria in type 2 diabetes mellitus

Cardiology (Switzerland)

Volumn 129, Issue 1, 2014, Pages 28-35

  Magri, Caroline J ^a,c   Xuereb, Robert G ^a,c   Fava, Stephen ^b,c  

^a MATER DEI HOSPITAL   (Malta)

^b UNIVERSITY OF MALTA   (Malta)

^c UNIVERSITY OF MALTA MEDICAL SCHOOL   (Malta)

Author keywords

Blood pressure; Diabetes mellitus; Heart rate; Platelet

Indexed keywords

ALBUMIN; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; CREATININE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; INSULIN; METFORMIN; ORAL ANTIDIABETIC AGENT; SULFONYLUREA; ACETYLSALICYLIC ACID; DIURETIC AGENT; FIBRIC ACID DERIVATIVE; HEMOGLOBIN A1C; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL; URIC ACID;

AGED; ALBUMINURIA; ARTICLE; ATHEROSCLEROSIS; BLOOD PRESSURE MONITORING; CARDIOVASCULAR RISK; COHORT ANALYSIS; CORRELATION ANALYSIS; CREATININE URINE LEVEL; CROSS-SECTIONAL STUDY; DIABETIC NEPHROPATHY; DIABETIC PATIENT; DIABETIC RETINOPATHY; DISEASE ASSOCIATION; DISEASE DURATION; EXPLORATORY RESEARCH; FEMALE; HEART RATE; HIGH RISK PATIENT; HUMAN; INFLAMMATION; INSULIN RESISTANCE; MAJOR CLINICAL STUDY; MALE; MICROALBUMINURIA; NON INSULIN DEPENDENT DIABETES MELLITUS; PERIPHERAL VASCULAR DISEASE; PRIORITY JOURNAL; THROMBOCYTE COUNT; CHOLESTEROL BLOOD LEVEL; COMPARATIVE STUDY; CONTROLLED STUDY; HEMOGLOBIN BLOOD LEVEL; HIGH RISK POPULATION; NON DIPPING HEART RATE; PROLIFERATIVE RETINOPATHY; RANDOMIZED CONTROLLED TRIAL; TRIACYLGLYCEROL BLOOD LEVEL; URIC ACID BLOOD LEVEL; ANALYSIS OF VARIANCE; CIRCADIAN RHYTHM; COMPLICATION; METABOLISM; MIDDLE AGED; PATHOPHYSIOLOGY; PHYSIOLOGY; RISK FACTOR;

AGED; ALBUMINURIA; ANALYSIS OF VARIANCE; CIRCADIAN RHYTHM; CREATININE; CROSS-SECTIONAL STUDIES; DIABETES MELLITUS, TYPE 2; FEMALE; HEART RATE; HUMANS; MALE; MIDDLE AGED; PLATELET COUNT; RISK FACTORS;

EID: 84902922630     PISSN: 00086312     EISSN: 14219751     Source Type: Journal    
DOI: 10.1159/000362714     Document Type: Article

References (31)

1. Kannel WB, Kannel C, Paffenbarger RS Jr, et al: Heart rate and cardiovascular mortality: the Framingham Study. Am Heart J 1987; 113: 1489-1494.
2. Dyer AR, Persky V, Stamler J, et al: Heart rate as a prognostic factor for coronary heart disease and mortality: findings in three Chicago epidemiologic studies. Am J Epidemiol 1980; 112: 736-749.
3. Gillman MW, Kannel WB, Belanger A, et al: Influence of heart rate on mortality among persons with hypertension: the Framingham Study. Am Heart J 1993; 125: 1148-1154.
4. Linn emann B, Janka HU: Prolonged QTc interval and elevated heart rate identify the type 2 diabetic patient at high risk for cardiovascular death: the Bremen Diabetes Study. Exp Clin Endocrinol Diabetes 2003; 111: 215-222.
5. Greenland P, Daviglus ML, Dyer AR, et al: Resting heart rate is a risk factor for cardiovascular and noncardiovascular mortality: the Chicago Heart Association Detection Project in Industry. Am J Epidemiol 1999; 149: 853-862.
6. Hjalmarson A, Gilpin EA, Kjekshus J, et al: Influence of heart rate on mortality after acute myocardial infarction. Am J Cardiol 1990; 65: 547-553.
7. Copie X, Hnatkova K, Staunton A, et al: Predictive power of increased heart rate versus depressed left ventricular ejection fraction and heart rate variability for risk stratification after myocardial infarction: results of a twoyear follow-up study. J Am Coll Cardiol 1996; 27: 270-276.
8. Lechat P, Hulot JS, Escolano S, et al: Heart rate and cardiac rhythm relationships with bisoprolol benefit in chronic heart failure in CIBI S II Trial. Circulation 2001; 103: 1428-1433.
9. Palatini P, Benetos A, Grassi G, et al: Identification and management of the hypertensive patient with elevated heart rate: statement of a European Society of Hypertension Consensus Meeting. J Hypertens 2006; 24: 603-610.
10. Deckert T, Feldt-Rasmussen B, Borch-Johnsen K, et al: Albuminuria reflects widespread vascular damage: the Steno hypothesis. Diabetologia 1989; 32: 219-226.
11. Bö hm M, Reil JC, Danchin N, et al: Association of heart rate with microalbuminuria in cardiovascular risk patients: data from ISEARCH. J Hypertens 2008; 26: 18-25.
12. Bö hm M, Thoenes M, Neuberger HR, et al: Atrial fibrillation and heart rate independently correlate to microalbuminuria in hypertensive patients. Eur Heart J 2009; 30: 1364-1371.
13. Cuspidi C, Valerio C, Meani S, et al: Ambulatory heart rate and target organ damage in never-treated essential hypertensives. J Hum Hypertens 2008; 22: 89-95.
14. Liu P, Wang SJ, Zhang Y: The relationship between resting heart rate and target organs damage in senile essential hypertension (in Chinese). Zhonghua Xin Xue Guan Bing Za Zhi 2005; 33: 49-53.
15. Pfister R, Erdmann E, Schneider CA: Association and prognostic impact of heart rate and micro-albuminuria in patients with type 2 diabetes and cardiovascular disease: results from the PROactive trial. J Atheroscler Thromb 201 1; 18: 65-71.
16. Verdecchia P, Schillaci G, Borgioni C, et al: Adverse prognostic value of a blunted circadian rhythm of heart rate in essential hypertension. J Hypertens 1998; 16: 1335-1343.
17. Ben-Dov IZ, Kark JD, Ben-Ishay D, et al: Blunted heart rate dip during sleep and allcause mortality. Arch Intern Med 2007; 167: 2116-2121.
18. Eguchi K, Hoshide S, Ishikawa J, et al: Nocturnal nondipping of heart rate predicts cardiovascular events in hypertensive patients. J Hypertens 2009; 27: 2265-2270.
19. Cuspidi C, Meani S, Negri F, et al: Is blunted heart rate decrease at night associated with prevalent organ damage in essential hypertension? Blood Press Monit 2011; 16: 16-21.
20. Kä rvestedt L, Martensson E, Grill V, et al: Peripheral sensory neuropathy associ ates with micro-or macroangiopathy: results from a population-based study of type 2 diabetic patients in Sweden. Diabetes Care 2009; 32: 317-322.
21. National Kidney Foundation: Calculators for health care professionals. http://www.kidney.org/professionals/kdoqi/gfr-calculator.cfm.
22. Matthews DR Hosker JP Rudenski AS et al Homeostasis model assessment: insulin resistance and β-cell function from fasting p lasma glucose and insulin concentrations in man Diabetologia 1985 28 412-419.
23. Alberti KG, Zimmet P, Shaw J, IDF Epidemiology Task Force Concensus Group: The metabolic syndrome-A new worldwide definition. Lancet 2005; 366: 1059-1062.
24. Nausch LW, Bonev AD, Heppner TJ, et al: Sympathetic nerve stimulation induces local endothelial Ca 2+ signals to oppose vasoconstriction of mouse mesent eric arteries. Am J Physiol Heart Circ Physiol 2012; 302:H594-H602.
25. Kaplon RE, Walker AE, Seals DR: Plasma norepinephrine is an independent predictor of vascular endothelial function with aging in healthy women. J Appl Physiol 2011; 111: 1416-1421.
26. Targoński R, Sadowski J: The effect of an evening dose of a long-acting β-blocker on the autonomic tone in patients with congestive heart failure. Kardiol Pol 2009; 67: 963-970.
27. Padil la J, Young CN, Simmons GH, et al: Increased muscle sympathetic nerve activity acutely alters conduit artery shear rate patterns. Am J Physiol Heart Circ Physiol 2010; 298:H1128-H1135.
28. Grassi G, Quarti-Trevano F, Seravalle G, et al: Early sympathetic activation in the initial clinical stages of chronic renal failure. Hypertension 2011; 57: 846-851.
29. Rauch U, Ziegler D, Pio lot R, et al: Platelet activation in diabetic cardiovascular autonomic neuropathy. Diabet Med 1999; 16: 848-852.
30. Ozdemir O, Soylu M, Alyan O, et al: Association between mean platelet volume and autonomic nervous system functions: increased mean platelet volume reflects sympathetic overactivity. Exp Clin Cardiol 2004; 9: 243-247.
31. Magri CJ, Calleja N, Buhagiar G, et al: Factors associated with diabetic nephropathy in subjects with proliferative retinopathy. Int Urol Nephrol 2012; 44: 197-206.